Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.

Conclusions: FMT restores alterations of the gut microenvironment in IBS-D patients during the first 3 weeks and improves their symptoms for up to 28 weeks. ClinicalTrials.gov ID: NCT03333291. PMID: 31190584 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31190584?dopt=Abstract

Source: Scandinavian Journal of Gastroenterology - June 15, 2019 Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research